| Drug metabolism in the liver OA Almazroo, MK Miah, R Venkataramanan Clinics in liver disease 21 (1), 1-20, 2017 | 630 | 2017 |
| Evaluation of thrombolytic activity of four Bangladeshi medicinal plants, as a possible renewable source for thrombolytic compounds MAA Sikder, AB Siddique, AKMN Hossian, MK Miah, MA Kaisar, ... Journal of Pharmacy and Nutrition Sciences 1 (1), 4-8, 2011 | 35 | 2011 |
| Open-label, multicenter, phase I study to assess safety and tolerability of adavosertib plus durvalumab in patients with advanced solid tumors. MR Patel, GS Falchook, JSZ Wang, E Rodrigo Imedio, S Kumar, ... Journal of Clinical Oncology 37 (15_suppl), 2562-2562, 2019 | 26 | 2019 |
| A phase 1b study to evaluate the safety and efficacy of durvalumab in combination with tremelimumab or danvatirsen in patients with relapsed or refractory diffuse large B-cell … V Ribrag, ST Lee, D Rizzieri, MJS Dyer, L Fayad, R Kurzrock, L Andritsos, ... Clinical Lymphoma Myeloma and Leukemia 21 (5), 309-317. e3, 2021 | 23 | 2021 |
| Evaluation of [14C] and [13C] Sucrose as Blood–Brain Barrier Permeability Markers MK Miah, EA Chowdhury, U Bickel, R Mehvar Journal of pharmaceutical sciences 106 (6), 1659-1669, 2017 | 22 | 2017 |
| Membrane stabilizing activity-a possible mechanism of action for the anti-inflammatory activity of two Bangladeshi medicinal plants: Mesua nagassarium (Burm. F.) and Kigelia … MA Rashid, MAA Sikder, MA Kaisar, MK Miah, MM Parvez, A Hossian IJPRD 3, 1-5, 2011 | 20 | 2011 |
| Effects of short-term portacaval anastomosis on the peripheral and brain disposition of the blood–brain barrier permeability marker sodium fluorescein in rats IH Shaik, MK Miah, U Bickel, R Mehvar Brain research 1531, 84-93, 2013 | 18 | 2013 |
| Clinical pharmacokinetics MK Miah, IH Shaik, FG Feturi, A Ali, R Venkataramanan Clinical pharmacy education, practice and research, 409-424, 2019 | 16 | 2019 |
| Polyphenols content, cytotoxic, membrane stabilizing and thrombolytic activities of Sarcolobus globosus: A medicinal plant from Sundarban forest MR Kuddus, F Aktar, MA RASHID Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 10 …, 2011 | 16 | 2011 |
| Effects of hepatic ischemia-reperfusion injury on the P-glycoprotein activity at the liver canalicular membrane and blood–brain barrier determined by in vivo administration of … MK Miah, IH Shaik, U Bickel, R Mehvar Pharmaceutical research 31, 861-873, 2014 | 14 | 2014 |
| Development and validation of a sensitive UPLC–MS/MS method for the quantitation of [13C] sucrose in rat plasma, blood, and brain: Its application to the measurement of blood … MK Miah, U Bickel, R Mehvar Journal of Chromatography B 1015, 105-110, 2016 | 13 | 2016 |
| An evaluation of the safety and preliminary efficacy of peri‐and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant … OA Almazroo, MK Miah, VC Pillai, IH Shaik, R Xu, S Dharmayan, ... Clinical Transplantation 35 (6), e14298, 2021 | 12 | 2021 |
| Reduced-concentration clavulanate for young children with acute otitis media A Hoberman, JL Paradise, HE Rockette, JH Jeong, DH Kearney, ... Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00238-17, 2017 | 12 | 2017 |
| Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [14C] and [13C]sucrose MK Miah, U Bickel, R Mehvar Metabolic Brain Disease 32, 1903-1912, 2017 | 11 | 2017 |
| Physiologically based pharmacokinetic approach can successfully predict pharmacokinetics of citalopram in different patient populations X Wu, H Zhang, MK Miah, SN Caritis, R Venkataramanan The Journal of Clinical Pharmacology 60 (4), 477-488, 2020 | 10 | 2020 |
| Effects of Pringle maneuver and partial hepatectomy on the pharmacokinetics and blood–brain barrier permeability of sodium fluorescein in rats MK Miah, IH Shaik, U Bickel, R Mehvar Brain research 1618, 249-260, 2015 | 9 | 2015 |
| Clinical pharmacokinetics of adavosertib in the presence or absence of PD-L1 inhibitor durvalumab in patients with refractory solid tumors MK Miah, ER Imedio, L Ottesen, S Kumar, G Mugundu European Journal of Cancer 138, S45, 2020 | 2 | 2020 |
| Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-ESMART trial SA Gatz, AC Harttrampf, C Brard, F Bautista, N André, S Abbou, J Rubino, ... Clinical Cancer Research 30 (4), 741-753, 2024 | 1 | 2024 |
| Abstract CT087: Phase I/II study of the WEE1 inhibitor adavosertib in combination with carboplatin in children with advanced malignancies: arm C of the AcSé-ESMART trial SA Gatz, AC Harttrampf, C Brard, FJ Bautista, N André, S Abbou, J Rubino, ... Cancer Research 83 (8_Supplement), CT087-CT087, 2023 | 1 | 2023 |
| A Phase 1 Study to Evaluate Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of Savolitinib in Healthy Male Volunteers K Miah, K Vishwanathan, G Scarfe, Y Li, I Hara, M Cantarini, J Argue, ... Clinical Pharmacology in Drug Development 12 (4), 424-435, 2023 | 1 | 2023 |
